J&J | JNJ - Interest Income

Stock Price
239.81
Daily Change
2.05 0.86%
Monthly
17.10%
Yearly
56.22%
Q1 Forecast
220.25

J&J reported $2.12 in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
Abbott USD 77M 6M Sep/2025
AstraZeneca USD 68M 16M Jun/2025
Baxter International USD 14M 3M Jun/2025
Bayer EUR 130M 38M Sep/2025
Becton, Dickinson and Co. USD 5M 0 Sep/2025
Biogen USD 32.3M 8.4M Jun/2025
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 28M 500K Jun/2025
Edwards Lifesciences USD 37.4M 26.6M Jun/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Globus Medical USD 815K 3.08M Dec/2024
Hologic USD 0.79 18.9M Dec/2025
Insulet USD 10.1M 200K Jun/2025
Integra LifeSciences USD 4.71M 290K Jun/2025
Intuitive Surgical USD 95.5M 6.8M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Medtronic USD 114M 23M Jan/2025
Merck USD 96M 27M Sep/2025
Merit Medical Systems USD 3.76M 29K Jun/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Sanofi EUR 114M 38M Sep/2025
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 4.19M 318K Mar/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025
Zoetis USD 19M 4M Jun/2025